Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: $INO

November 1, 2026

FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 11-01-2026 TO 11-07-2026

I’m excited to announce the release of my latest FREE bio tech stock catalyst report for the upcoming week. This new FREE stock report highlights bio tech companies that have an important upcoming event and an expected price move of 20 percent up or down ($ +/- 20%) to help you make informed market decisions.…

FREE Weekly Stock Catalyst Report

$AKTX, $IMUX, $INO, $IVA, biopharmaceutical, FDA Approval, pr-newswire, press-releases
October 31, 2026

A Breakthrough in Rare Disease: FDA Grants Accelerated Approval to Voceryq

NASDAQ: $INO New Hope for Patients with Dystrophic Epidermolysis Bullosa The medical community is celebrating a significant milestone in genetic medicine. The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Voceryq (beremagene geperpavec-svdt), a transformative gene therapy designed to treat wounds in patients aged 6 months and older with dystrophic epidermolysis…

FDA Acceptance

$INO, Dystrophic Epidermolysis Bullosa, FDA Approval, gene therapy, Inovio Pharmaceuticals Inc, Rare Diseases, Voceryq

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Buy A Premium Report To Maximize Your Returns

The FREE bio tech stock catalyst report ONLY includes companies with catalysts within the current week. Often, this may not be enough time to capture the pre-catalyst stock price movements. For MAX RETURNS, buy a premium report below with longer outlooks, allowing you to discover earlier trade entries. Get positioned BEFORE a price move happens. Don’t miss out, maximize your return potential!

Choose your outlook window (each priced accordingly)

Get FREE Biotech Stock Catalyst Reports

Email